IP Library Patent Application 12480452
Patent Application
App. No. 12/480,452

AUTOMATED IMAGE ANALYSIS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/480,452
Abstract

One automated imaging process, as described herein, includes: a) obtaining digital images of objects in a biological sample; b) selecting a plurality of objects of interest from the digital images; c) obtaining multiple images of the selected objects of interest at a plurality of different wavelengths; d) combining one of said multiple images with a corresponding digital image to produce a combined image; and e) analyzing the combined image in order to characterize the biological sample.

Claims (31)

1 . An automated imaging process, comprising:

obtaining digital images of objects in a biological sample;

selecting a plurality of objects of interest from the digital images;

obtaining multiple images of the selected objects of interest at a plurality of different wavelengths;

combining two or more of said multiple images to produce a combined image of the selected objects; and

analyzing the combined image in order to characterize the selected objects.

2 . The automated imaging process of claim 1 , wherein the objects of interest comprise objects of relatively high optical density compared with other objects in the biological sample.

3 . The automated imaging process of claim 1 , wherein the digital images are obtained from at least one wavelength in the range from ultraviolet to infrared.

4 . The automated imaging process of claim 3 , wherein the digital images are obtained from at least one wavelength of less than about 670 nm.

5 . The automated imaging process of claim 1 , wherein the plurality of different wavelengths are at uniform increments.

6 . The automated imaging process of claim 1 , wherein the objects of interest comprise cells.

7 . The automated imaging process of claim 1 , wherein the process is used to determine a normal specimen.

8 . The automated imaging process of claim 1 , wherein the process is used to identify an infection or other disease.

9 . The automated imaging process of claim 1 , wherein the characterization of the selected objects includes detection of a marker.

10 . The automated imaging process of claim 1 , wherein the characterization of the selected objects comprises detection of a spectral signature of an abnormal or infected cell.

11 . An automated imaging process, comprising:

obtaining digital images of objects in a biological sample;

selecting at least one object of interest from the digital images;

obtaining at least one image of the at least one selected object of interest at a plurality of different wavelengths to form a set of multi-wavelength images;

analyzing the set of multi-wavelength images in order to characterize the at least one selected object.

12 . The automated imaging process of claim 11 , wherein the at least one object of interest comprises an object of relatively high optical density relative to other objects in the biological sample.

13 . The automated imaging process of claim 11 , wherein the digital images are obtained from at least one wavelength in the range from ultraviolet to infrared.

14 . The automated imaging process of claim 13 , wherein the digital images are obtained from at least one wavelength of less than about 670 nm.

15 . The automated imaging process of claim 11 , wherein the plurality of different wavelengths are at uniform increments.

16 . The automated imaging process of claim 11 , wherein the at least one object of interest comprise cells.

17 . The automated imaging process of claim 16 , wherein the process is used to identify a nucleus.

18 . The automated imaging process of claim 17 , wherein the process is used to identify the density of the nucleus.

19 . The automated imaging process of claim 11 , wherein the characterization of the selected object includes detection of a marker.

20 . The automated imaging process of claim 11 , wherein the process is used to determine a normal specimen.

21 . The automated imaging process of claim 11 , wherein the process is used to identify an infection or other disease.

22 . The automated imaging process of claim 11 , wherein the characterization of the selected object comprises detection of a spectral signature of an abnormal or infected cell.

Assignments (2)
TERMINATION OF PATENT SECURITY AGREEMENTS AND RELEASE OF SECURITY INTERESTS Recorded Aug 26, 2010
From: GOLDMAN SACHS CREDIT PARTNERS, L.P., AS COLLATERAL AGENT
To: HOLOGIC, INC.; R2 TECHNOLOGY, INC.; SUROS SURGICAL SYSTEMS, INC.; BIOLUCENT, LLC; DIRECT RADIOGRAPHY CORP.; CYTYC SURGICAL PRODUCTS II LIMITED PARTNERSHIP; CYTYC SURGICAL PRODUCTS LIMITED PARTNERSHIP; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS III, INC.; CYTYC PRENATAL PRODUCTS CORP.; THIRD WAVE TECHNOLOGIES, INC.
Reel/Frame 024892/0001 →
TWELFTH SUPPLEMENT TO PATENT SECURITY AGREEMENT Recorded Jul 28, 2009
From: CYTYC CORPORATION
To: GOLDMAN SACHS CREDIT PARTNERS L.P., AS COLLATERAL AGENT
Reel/Frame 023012/0568 →